RY

169.03

+0.4%↑

TD

94.04

+1.07%↑

BMO

133.73

+0.78%↑

BNS

73.25

+0.59%↑

CM

92.11

+0.59%↑

RY

169.03

+0.4%↑

TD

94.04

+1.07%↑

BMO

133.73

+0.78%↑

BNS

73.25

+0.59%↑

CM

92.11

+0.59%↑

RY

169.03

+0.4%↑

TD

94.04

+1.07%↑

BMO

133.73

+0.78%↑

BNS

73.25

+0.59%↑

CM

92.11

+0.59%↑

RY

169.03

+0.4%↑

TD

94.04

+1.07%↑

BMO

133.73

+0.78%↑

BNS

73.25

+0.59%↑

CM

92.11

+0.59%↑

RY

169.03

+0.4%↑

TD

94.04

+1.07%↑

BMO

133.73

+0.78%↑

BNS

73.25

+0.59%↑

CM

92.11

+0.59%↑

Search

Hercules Capital Inc

Atvērts

SektorsFinanšu

18.93 1.23

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

18.66

Max

18.94

Galvenie mērījumi

By Trading Economics

Ienākumi

61M

119M

Pārdošana

89M

169M

P/E

Sektora vidējais

10.73

28.186

Dividenžu ienesīgums

8.61

Peļņas marža

70.164

Darbinieki

100

EBITDA

18M

120M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+9.5% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

8.61%

4.24%

Nākamie ieņēmumi

2026. g. 12. febr.

Nākamais dividenžu datums

2026. g. 4. marts

Nākamais Ex dividenžu datums

2026. g. 25. febr.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

128M

3.4B

Iepriekšējā atvēršanas cena

17.7

Iepriekšējā slēgšanas cena

18.93

Ziņu noskaņojums

By Acuity

50%

50%

180 / 493 Rangs Finance

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

Hercules Capital Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 14. janv. 22:41 UTC

Iegādes, apvienošanās, pārņemšana

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

2026. g. 15. janv. 00:00 UTC

Peļņas

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

2026. g. 14. janv. 23:47 UTC

Tirgus saruna

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

2026. g. 14. janv. 23:44 UTC

Tirgus saruna

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

2026. g. 14. janv. 23:39 UTC

Tirgus saruna

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

2026. g. 14. janv. 23:32 UTC

Tirgus saruna

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

2026. g. 14. janv. 22:56 UTC

Iegādes, apvienošanās, pārņemšana

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

2026. g. 14. janv. 22:53 UTC

Iegādes, apvienošanās, pārņemšana

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

2026. g. 14. janv. 22:17 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 14. janv. 22:17 UTC

Tirgus saruna

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

2026. g. 14. janv. 22:09 UTC

Peļņas

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

2026. g. 14. janv. 22:08 UTC

Peļņas

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

2026. g. 14. janv. 22:08 UTC

Peļņas

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

2026. g. 14. janv. 21:53 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

2026. g. 14. janv. 21:53 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

2026. g. 14. janv. 21:52 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Announces Positive Profit Alert for 2025

2026. g. 14. janv. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

Citigroup Acting as Financial Advisor to WuXi XDC

2026. g. 14. janv. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC: Aims to Keep Listing Status of BioDlink

2026. g. 14. janv. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

2026. g. 14. janv. 21:50 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2026. g. 14. janv. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 14. janv. 21:49 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC: BioDlink Offer to Cost HK$2.79B

2026. g. 14. janv. 21:48 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

2026. g. 14. janv. 21:48 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Makes Cash Offer for BioDlink International

2026. g. 14. janv. 21:13 UTC

Tirgus saruna

Oil Retreats Late After Trump Comments on Iran -- Market Talk

2026. g. 14. janv. 20:30 UTC

Tirgus saruna
Peļņas

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

2026. g. 14. janv. 20:13 UTC

Tirgus saruna

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

2026. g. 14. janv. 20:08 UTC

Tirgus saruna

Oil Futures Extend Rally on Iran Tensions -- Market Talk

2026. g. 14. janv. 19:33 UTC

Tirgus saruna

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

2026. g. 14. janv. 19:06 UTC

Tirgus saruna
Peļņas

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Salīdzinājums

Cenas izmaiņa

Hercules Capital Inc Prognoze

Cenas mērķis

By TipRanks

9.5% augšup

Prognoze 12 mēnešiem

Vidējais 20.29 USD  9.5%

Augstākais 24 USD

Zemākais 18 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Hercules Capital Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

6 ratings

6

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

17.41 / 17.93Atbalsts un pretestība

Īstermiņā

Neutral Evidence

Vidējā termiņā

Strong Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

180 / 493 Rangs Finanšu

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Vidējais

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Hercules Capital Inc

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable
help-icon Live chat